https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-loses-us-appeal-over-co-pays-heart-failure-patients-2022-07-25/
Jefferies Initiates Coverage On Vitesse Energy with Buy Rating, Announces Price Target of $23
Jefferies analyst Lloyd Byrne initiates coverage on Vitesse Energy (NYSE:VTS) with a Buy rating and announces Price Target of $23.